Monson Jonathan 4

4 · BOSTON SCIENTIFIC CORP · Filed Feb 20, 2024

Form 4

Period: 2024-02-16

EVP and CFO

Transactions

Exercise/Conversion
Common Stock
2024-02-16+990→ 37,433 total
Tax Payment
Common Stock
2024-02-16$65.82/sh−427$28,105→ 37,006 total
Exercise/Conversion
Common Stock
2024-02-17+1,000→ 38,006 total
Tax Payment
Common Stock
2024-02-17$65.82/sh−404$26,591→ 37,602 total
Exercise/Conversion
Common Stock
2024-02-18+638→ 38,240 total
Tax Payment
Common Stock
2024-02-18$65.82/sh−258$16,982→ 37,982 total
Exercise/Conversion
Restricted Stock Units
2024-02-16−990→ 1,980 total
Exp: 2026-02-16→ Common Stock (990 underlying)
Exercise/Conversion
Restricted Stock Units
2024-02-17−1,000→ 1,000 total
Exp: 2025-02-17→ Common Stock (1,000 underlying)
Exercise/Conversion
Deferred Stock Units
2024-02-18−638→ 0 total
Exp: 2024-02-18→ Common Stock (638 underlying)

Footnotes (5)

[F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
[F2]Each deferred stock unit represents the Company's commitment to issue on share of Boston Scientific common stock.
[F3]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 16, 2023, the first anniversary of the date of grant.
[F4]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
[F5]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.

Documents

1 file